Actual Medicinal Product (AMP) Tramadol 50mg capsules (Actavis UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No stability data in MCAs available but no theoretical concerns with product.
Anecdotal reports of use in MCA for 7 days. - Provenance
-
This recommendation is based on the products Zamadol 50mg capsules (Viatris) and Tramadol hydrochloride 50mg capsules (Amarox Limited).
- Generic
- Tramadol
- Formulation
- Tramadol 50mg capsules
-
Tramadol
-
Tramadol 50mg capsules
-
Tramadol 50mg capsules (Actavis UK Ltd)
-
-
Tramadol 50mg soluble tablets sugar free
Tramadol 200mg modified-release tablets
Tramadol 300mg modified-release tablets